Header Ads

Health Ministry introduces Online PG Applications for all Medical Colleges




Health Ministry introduces Online PG Applications for all Medical Colleges 

Ministry of Health and Family Welfare has introduced a new procedure for submitting application/proposal for application to Medical Colleges. It is an add-on procedure which will run parallel with conventional procedure of manual submission of applications. As per the revised procedure an online application is mandatory and comes into effect from 15-03-2016. The last date for application is 7th April, 2016. 


 Applicant/Colleges desirous of filing an application for purposes of (i) Starting of PG courses (Broad Specialities) and/or (ii) Increase of seats in PG courses (Broad Specialities), in an existing Medical College are requested to follow these steps: 

 Visit www.mohfw.nic.in, and click on the link medicalcollegeappication.gov.in. Candidates are requested to do a ‘one time registration’ using a valid email-address at the ‘registration window’ provided at the link. After the successful registration, applicant will obtain an ID (colleges registered last year may use the previous login ID and Password). Candidate shall login using the provided ID and Password and shall read and accept the Terms of Online Application. All the ‘enabled’ columns of the application form must be filled. Applicants are also requested to upload a scanned copy of consent of University Affiliation, Demand Draft (as evidence of Fee paid) and any other document, if required. The application shall be uploaded thereafter. An acknowledgement, provided after successful submission of the application-form, shall be kept/saved by the applicants for any further follow-up. 

 Applicants are also requested to file a manual copy of the complete application as prescribed by the MCI Regulation, along with all valid documents along with a Draft in original as evidence of the fee-paid and a ‘signed copy’ of the system generated online application acknowledgement on or before due date and time as notified. It may be noted that an online application is not a complete application and only on fulfilment of the above mentioned condition, an application will be deemed to be complete. 

*********

Shri J P Nadda launches new initiatives to combat TB 

 Government of India committed to accelerate efforts to fight tuberculosis in the country: Shri J P Nadda 

“The Government of India stands committed to accelerating its efforts to combat tuberculosis in the country”, stated Shri J P Nadda, Union Minister of Health and Family Welfare. He was speaking on the eve of ‘World TB Day’, here today. He stated that the process of fighting TB is continuous, hence there can be no dilution and do diversion. Our attention needs to steadfast and aggressive, stated the Health Minister. He further added that resources will not be a constraint and the Government will continue to work with all stakeholders, in devising short term and long term approaches. Shri Nadda also emphasized the need for compassion in the treatment of TB patients. 

 At the event, Shri J P Nadda, launched Bedaquiline – new anti-TB drug for Drug Resistant TB as part of the RNTCP. The drug is a new anti-TB drug for treatment of MDR-TB. This new class of drug is a diarylquinoline that specifically targets Mycobacterial ATP synthase, an enzyme essential for supply of energy to Mycobacterium tuberculosis and most other mycobacteria. This drug is indicated for use in the treatment of drug-resistant TB. Bedaquiline is being introduced at six identified tertiary care centres across India. These sites have advanced facilities for laboratory testing and intensive care for patients. Bedaquiline will be given to multi-drug resistant TB patients with resistance to either all fluoroquinolone and/or all second line injectables and extensive drug resistant TB. 

 Shri Nadda also inducted over 500 Cartridge Based Nucleic Acid Amplification Test (CBNAAT) machines in the programme. The CBNAAT is a revolutionary rapid molecular test which detects Mycobacterium tuberculosis and rifampicin drug resistance, simultaneously. This test is fully automated and provides results within two hours. It is a highly sensitive diagnostic tool and can be used in remote and rural areas without sophisticated infrastructure or specialized training. Until 2015, 121 CBNAAT sites are functional in the country largely providing decentralized testing for detection of DR TB. With the availability of these additional 500 machines, access to rapid quality assured diagnosis of DR TB and TB will be ensured in all the districts of India either directly or through a linkage by specimen transport mechanism. Additionally, the programme will be able to use this highly sensitive state-of-art technology for diagnosis of TB among key populations like children, PLHIV and extra pulmonary TB patients. 

 The Health Minister also released the TB India 2016 Annual Report and the Technical and Operational Guidelines for TB Control in India 2016. The comprehensive set of guidelines are for management of all forms of TB, including drug resistant TB and strategies for intensified case finding; adherence of more patient centric approaches; and single-window care for patients suffering from HIV and TB. A handbook for ‘Healthcare Worker surveillance for TB in India’ and Guidelines for Prevention and Management of Adverse reactions associated with anti-TB drugs were the other e-book launch at the event. A new radio campaign with TB ambassador Amitabh Bachchan and social media campaign, was also launched at the event. 

 The Minister also launched the ‘Third line ART programme for People Living with HIV’. The life-saving third line ART costs nearly Rs. 1.18 lakh per patient per year. Providing these free would not only safe lives but improve socioeconomic conditions of the patients. This initiative brings India’s ART programme at par with programmes in the developed countries. 

 Shri B P Sharma, Secretary (HFW) highlighted the need for collective commitment of all stakeholders. He stated that the Revised National Tuberculosis Control Program (RNTCP) is one of the most successful programmes. “The programme has made significant impact on prevalence and treatment of TB”, said Shri B P Sharma. He further added that 300 CBNAAT machines have already been installed and 200 more will be installed soon. “Quality of treatment has to be even over the public and private sectors. It has to be well supported by a strong procurement so that it can be sustained till 2030, said Shri B P Sharma. Secretary (Health) also laid emphasis on surveillance and monitoring. He said that we need new tools for diagnostics and new research. He further said that delivery mechanism should be in conformity with goals we have set for ourselves. 

 Speaking on the occasion, Dr Saumya Swaminathan, Secretary (DHR) and DG (ICMR), highlighted the challenges of the frontline health workers. She said that there is a need for new and innovative tools for conducting tests and investment in research. She further added that we need to use drugs optimally. 

 Also present on this occasion were, Dr. (Prof) Jagdish Prasad, DGHS, Shri C K Mishra, AS & MD, and other senior officers of the Health Ministry, representatives of WHO, World Bank and other development partners. 

No comments

Powered by Blogger.